Why Are So Few Blockbuster Drugs Invented Today?
In the fall of 1999, a young chemical engineer named Todd Zion left his job at Eastman Kodak to enroll in the Ph.D. program at the Massachusetts Institute of Technology. While looking for a subject to research, Zion noticed a grant proposal, never funded, that another graduate student had written on the subject of drug delivery.
Continue Reading http://www.nytimes.com
Join the Discussion